Brief: Xoma Royalty And Takeda Execute Strategic Royalty Sharing Transaction And Amend Existing Agreement For Mezagitamab

Xoma Royalty

30/12/2025 13:32

Dec 30 (Reuters) - Xoma Royalty Corp XOMA.O:

XOMA ROYALTY AND TAKEDA EXECUTE STRATEGIC ROYALTY SHARING TRANSACTION AND AMEND EXISTING AGREEMENT FOR MEZAGITAMAB

XOMA ROYALTY CORP - TAKEDA REGAINS MAJORITY ROYALTY INTEREST IN MEZAGITAMAB

XOMA ROYALTY CORP - RETAINS LOW ROYALTY AND $13 MILLION IN MILESTONES FOR MEZAGITAMAB

XOMA ROYALTY: ENTITLED TO PAYMENTS ASSOCIATED WITH NINE DEVELOPMENT-STAGE ASSETS HELD WITHIN TAKEDA'S EXTERNALIZED ASSETS PORTFOLIO

Source text: ID:nGNX8932Cx

Further company coverage: XOMA.O

 ((Reuters.Briefs@thomsonreuters.com;))